Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1988 Oct;58(4):493–496. doi: 10.1038/bjc.1988.247

High dose ketoconazole: endocrine and therapeutic effects in postmenopausal breast cancer.

A L Harris 1, B M Cantwell 1, M Dowsett 1
PMCID: PMC2246803  PMID: 2974717

Abstract

Ketoconazole, an antifungal agent, inhibits in vitro C17-C20 lyase, an enzyme involved in androgen biosynthesis. Since adrenal and ovarian androgens are the main precursors of oestrogens in postmenopausal women, the endocrine and therapeutic effects of high dose ketoconazole (400 mg three times a day) were evaluated in 14 postmenopausal women with advanced breast cancer. Testosterone levels were suppressed significantly (37%, P less than 0.025), as was dehydroepiandrosterone sulphate, and androstenedione levels showed a similar but non-significant fall. Seventeen hydroxyprogesterone levels rose significantly, as would be expected if C17-C20 lyase was inhibited. There was no suppression of cortisol or oestrone levels. There was a small suppression of oestradiol concentrations, reflecting a decrease in its precursor, testosterone. Sex hormone binding globulin levels rose, which may be due to a decrease in testosterone. All the changes are compatible with C17-C20 lyase as a major site of action in vivo. No responses occurred in 12 patients treated with ketoconazole alone, but in 2 patients who were progressing on aminoglutethimide, testosterone levels were suppressed and in one patient a partial response occurred. Ketoconazole was poorly tolerated due to gastrointestinal toxicity. This study shows that C17-C20 lyase is a potential target for hormone therapy, and that sequential blockade of enzymes involved in oestrogen biosynthesis should be further evaluated.

Full text

PDF
494

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abul-Hajj Y. J., Iverson R., Kiang D. T. Metabolism of pregnenolone by human breast cancer. Evidence for 17 alpha-hydroxylase and 17,20-lyase. Steroids. 1979 Dec;34(7):817–827. doi: 10.1016/0039-128x(79)90094-1. [DOI] [PubMed] [Google Scholar]
  2. Alexieva-Figusch J., de Jong F. H., Lamberts W. J., van Gilse H. A., Klign J. G. Endocrine effects of aminoglutethimide plus hydrocortisone versus effects of high dose of hydrocortisone alone in postmenopausal metastatic breast cancer. Eur J Cancer Clin Oncol. 1987 Sep;23(9):1349–1356. doi: 10.1016/0277-5379(87)90119-2. [DOI] [PubMed] [Google Scholar]
  3. Allen J. M., Kerle D. J., Ware H., Doble A., Williams G., Bloom S. R. Combined treatment with ketoconazole and luteinising hormone releasing hormone analogue: a novel approach to resistant progressive prostatic cancer. Br Med J (Clin Res Ed) 1983 Dec 10;287(6407):1766–1766. doi: 10.1136/bmj.287.6407.1766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Anderson D. C. Sex-hormone-binding globulin. Clin Endocrinol (Oxf) 1974 Jan;3(1):69–96. doi: 10.1111/j.1365-2265.1974.tb03298.x. [DOI] [PubMed] [Google Scholar]
  5. Ayub M., Stitch S. R. Effect of ketoconazole on placental aromatase, 3 beta-hydroxysteroid dehydrogenase-isomerase and 17 beta-hydroxysteroid dehydrogenase. J Steroid Biochem. 1986 Dec;25(6):981–984. doi: 10.1016/0022-4731(86)90332-8. [DOI] [PubMed] [Google Scholar]
  6. Bezwoda W. R., Mansoor N., Dansey R. Correlation of breast tumour aromatase activity and response to aromatase inhibition with aminoglutethimide. Oncology. 1987;44(6):345–349. doi: 10.1159/000226509. [DOI] [PubMed] [Google Scholar]
  7. Blake R. E., Rajguru S., Nolan G. H., Ahluwalia B. S. Dexamethasone suppresses sex-hormone binding globulin. Fertil Steril. 1988 Jan;49(1):66–70. [PubMed] [Google Scholar]
  8. Brass C., Galgiani J. N., Blaschke T. F., Defelice R., O'Reilly R. A., Stevens D. A. Disposition of ketoconazole, an oral antifungal, in humans. Antimicrob Agents Chemother. 1982 Jan;21(1):151–158. doi: 10.1128/aac.21.1.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Couch R. M., Muller J., Perry Y. S., Winter J. S. Kinetic analysis of inhibition of human adrenal steroidogenesis by ketoconazole. J Clin Endocrinol Metab. 1987 Sep;65(3):551–554. doi: 10.1210/jcem-65-3-551. [DOI] [PubMed] [Google Scholar]
  10. Craven P. C., Graybill J. R., Jorgensen J. H., Dismukes W. E., Levine B. E. High-dose ketoconazole for treatment of fungal infections of the central nervous system. Ann Intern Med. 1983 Feb;98(2):160–167. doi: 10.7326/0003-4819-98-2-160. [DOI] [PubMed] [Google Scholar]
  11. DeFelice R., Johnson D. G., Galgiani J. N. Gynecomastia with ketoconazole. Antimicrob Agents Chemother. 1981 Jun;19(6):1073–1074. doi: 10.1128/aac.19.6.1073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. DiMattina M., Maronian N., Ashby H., Loriaux D. L., Albertson B. D. Ketoconazole inhibits multiple steroidogenic enzymes involved in androgen biosynthesis in the human ovary. Fertil Steril. 1988 Jan;49(1):62–65. doi: 10.1016/s0015-0282(16)59649-6. [DOI] [PubMed] [Google Scholar]
  13. Dowsett M., Cantwell B., Lal A., Jeffcoate S. L., Harris A. L. Suppression of postmenopausal ovarian steroidogenesis with the luteinizing hormone-releasing hormone agonist goserelin. J Clin Endocrinol Metab. 1988 Apr;66(4):672–677. doi: 10.1210/jcem-66-4-672. [DOI] [PubMed] [Google Scholar]
  14. Feldman L. D. Ketoconazole for male metastatic breast cancer. Ann Intern Med. 1986 Jan;104(1):123–124. doi: 10.7326/0003-4819-104-1-123_2. [DOI] [PubMed] [Google Scholar]
  15. Grodin J. M., Siiteri P. K., MacDonald P. C. Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab. 1973 Feb;36(2):207–214. doi: 10.1210/jcem-36-2-207. [DOI] [PubMed] [Google Scholar]
  16. Harris A. L., Dowsett M., Smith I. E., Jeffcoate S. L. Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer. Br J Cancer. 1983 May;47(5):621–627. doi: 10.1038/bjc.1983.100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Harris A. L., Dowsett M., Smith I. E., Jeffcoate S. Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer. Br J Cancer. 1983 Oct;48(4):585–594. doi: 10.1038/bjc.1983.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Harris A. L., Dowsett M., Smith I. E., Jeffcoate S. Hydrocortisone alone vs hydrocortisone plus aminoglutethimide: a comparison of the endocrine effects in postmenopausal breast cancer. Eur J Cancer Clin Oncol. 1984 Apr;20(4):463–469. doi: 10.1016/0277-5379(84)90230-x. [DOI] [PubMed] [Google Scholar]
  19. Judd H. L., Judd G. E., Lucas W. E., Yen S. S. Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab. 1974 Dec;39(6):1020–1024. doi: 10.1210/jcem-39-6-1020. [DOI] [PubMed] [Google Scholar]
  20. Judd H. L., Shamonki I. M., Frumar A. M., Lagasse L. D. Origin of serum estradiol in postmenopausal women. Obstet Gynecol. 1982 Jun;59(6):680–686. [PubMed] [Google Scholar]
  21. Kan P. B., Hirst M. A., Feldman D. Inhibition of steroidogenic cytochrome P-450 enzymes in rat testis by ketoconazole and related imidazole anti-fungal drugs. J Steroid Biochem. 1985 Dec;23(6A):1023–1029. doi: 10.1016/0022-4731(85)90062-7. [DOI] [PubMed] [Google Scholar]
  22. Kowal J. The effect of ketoconazole on steroidogenesis in cultured mouse adrenal cortex tumor cells. Endocrinology. 1983 Apr;112(4):1541–1543. doi: 10.1210/endo-112-4-1541. [DOI] [PubMed] [Google Scholar]
  23. Lake-Bakaar G., Scheuer P. J., Sherlock S. Hepatic reactions associated with ketoconazole in the United Kingdom. Br Med J (Clin Res Ed) 1987 Feb 14;294(6569):419–422. doi: 10.1136/bmj.294.6569.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lambert A., Mitchell R., Robertson W. R. The effect of ketoconazole on adrenal and testicular steroidogenesis in vitro. Biochem Pharmacol. 1986 Nov 15;35(22):3999–4004. doi: 10.1016/0006-2952(86)90018-3. [DOI] [PubMed] [Google Scholar]
  25. Loose D. S., Kan P. B., Hirst M. A., Marcus R. A., Feldman D. Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes. J Clin Invest. 1983 May;71(5):1495–1499. doi: 10.1172/JCI110903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Malozowski S., Young I., Garcia H., Simoni C., Loriaux D. L., Cassorla F. Effects of ketoconazole on rat testicular steroidogenic enzymatic activities. Steroids. 1985 Jul;46(1):659–663. doi: 10.1016/0039-128x(85)90029-7. [DOI] [PubMed] [Google Scholar]
  27. McCance D. R., Hadden D. R., Kennedy L., Sheridan B., Atkinson A. B. Clinical experience with ketoconazole as a therapy for patients with Cushing's syndrome. Clin Endocrinol (Oxf) 1987 Nov;27(5):593–599. doi: 10.1111/j.1365-2265.1987.tb01189.x. [DOI] [PubMed] [Google Scholar]
  28. Mehta R. R., Valcourt L., Graves J., Green R., Das Gupta T. K. Subcellular concentrations of estrone, estradiol, androstenedione and 17 beta-hydroxysteroid dehydrogenase (17-beta-OH-SDH) activity in malignant and non-malignant human breast tissues. Int J Cancer. 1987 Sep 15;40(3):305–308. doi: 10.1002/ijc.2910400304. [DOI] [PubMed] [Google Scholar]
  29. Nagai K., Miyamori I., Takeda R., Suhara K., Katagiri M. Effect of ketoconazole, etomidate and other inhibitors of steroidogenesis on cytochrome P-450sccII-catalyzed reactions. J Steroid Biochem. 1987 Sep;28(3):333–336. doi: 10.1016/0022-4731(87)91027-2. [DOI] [PubMed] [Google Scholar]
  30. Nakajin S., Hall P. F. Microsomal cytochrome P-450 from neonatal pig testis. Purification and properties of A C21 steroid side-chain cleavage system (17 alpha-hydroxylase-C17,20 lyase). J Biol Chem. 1981 Apr 25;256(8):3871–3876. [PubMed] [Google Scholar]
  31. Pont A., Graybill J. R., Craven P. C., Galgiani J. N., Dismukes W. E., Reitz R. E., Stevens D. A. High-dose ketoconazole therapy and adrenal and testicular function in humans. Arch Intern Med. 1984 Nov;144(11):2150–2153. [PubMed] [Google Scholar]
  32. Pont A. Long-term experience with high dose ketoconazole therapy in patients with stage D2 prostatic carcinoma. J Urol. 1987 May;137(5):902–904. doi: 10.1016/s0022-5347(17)44290-x. [DOI] [PubMed] [Google Scholar]
  33. Pont A., Williams P. L., Azhar S., Reitz R. E., Bochra C., Smith E. R., Stevens D. A. Ketoconazole blocks testosterone synthesis. Arch Intern Med. 1982 Nov;142(12):2137–2140. [PubMed] [Google Scholar]
  34. Pont A., Williams P. L., Loose D. S., Feldman D., Reitz R. E., Bochra C., Stevens D. A. Ketoconazole blocks adrenal steroid synthesis. Ann Intern Med. 1982 Sep;97(3):370–372. doi: 10.7326/0003-4819-97-3-370. [DOI] [PubMed] [Google Scholar]
  35. Santen R. J., Van den Bossche H., Symoens J., Brugmans J., DeCoster R. Site of action of low dose ketoconazole on androgen biosynthesis in men. J Clin Endocrinol Metab. 1983 Oct;57(4):732–736. doi: 10.1210/jcem-57-4-732. [DOI] [PubMed] [Google Scholar]
  36. Schieweck K., Bhatnagar A. S., Matter A. CGS 16949A, a new nonsteroidal aromatase inhibitor: effects on hormone-dependent and -independent tumors in vivo. Cancer Res. 1988 Feb 15;48(4):834–838. [PubMed] [Google Scholar]
  37. Sikka S. C., Swerdloff R. S., Rajfer J. In vitro inhibition of testosterone biosynthesis by ketoconazole. Endocrinology. 1985 May;116(5):1920–1925. doi: 10.1210/endo-116-5-1920. [DOI] [PubMed] [Google Scholar]
  38. Wander H. E., Blossey H. C., Nagel G. A. Aminoglutethimide in the treatment of premenopausal patients with metastatic breast cancer. Eur J Cancer Clin Oncol. 1986 Nov;22(11):1371–1374. doi: 10.1016/0277-5379(86)90147-1. [DOI] [PubMed] [Google Scholar]
  39. White M. C., Kendall-Taylor P. Adrenal hypofunction in patients taking ketoconazole. Lancet. 1985 Jan 5;1(8419):44–45. doi: 10.1016/s0140-6736(85)90988-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES